{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T10:24:16Z","timestamp":1778495056154,"version":"3.51.4"},"reference-count":26,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T00:00:00Z","timestamp":1721606400000},"content-version":"am","delay-in-days":295,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Gynecology Obstetrics and Human Reproduction"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.jogoh.2023.102630","type":"journal-article","created":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T22:12:19Z","timestamp":1689199939000},"page":"102630","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Late cervical and vaginal clear cell adenocarcinoma in women exposed in utero to diethylstilbestrol: Evaluation and screening"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2629-0195","authenticated-orcid":false,"given":"Michel","family":"Tournaire","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Gondry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00e9a","family":"Mauny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel","family":"Devouche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Morice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jogoh.2023.102630_bib0001","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2515\/therapie\/2014012","article-title":"Diethylstilbestrol story","volume":"69","author":"Tournaire","year":"2014","journal-title":"Therapie"},{"key":"10.1016\/j.jogoh.2023.102630_bib0002","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1056\/NEJMoa1013961","article-title":"Adverse health outcomes in women exposed in utero to diethylstilbestrol","volume":"365","author":"Hoover","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jogoh.2023.102630_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2016.03.007","article-title":"Prenatal diethylstilbestrol exposure and high-grade squamous cell neoplasia of the lower genital tract","volume":"215","author":"Troisi","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogoh.2023.102630_bib0004","unstructured":"Hatch E., Karam A. Outcome and follow-up of diethylstilbestrol (DES) exposed individuals. UpToDate. Available at: https:\/\/www.uptodate.com\/contents\/outcome-and-follow-up-of-diethylstilbestrol-des-exposed-individuals ; 2022 [accessed on March 21, 2020 and March 30, 2023]."},{"key":"10.1016\/j.jogoh.2023.102630_bib0005","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1002\/(SICI)1097-0142(19970601)79:11<2229::AID-CNCR22>3.0.CO;2-X","article-title":"Clear cell adenocarcinoma of the vagina and cervix. An update of the central Netherlands registry showing twin age incidence peaks","volume":"79","author":"Hanselaar","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.jogoh.2023.102630_bib0006","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1001\/journalofethics.2015.17.9.mhst1-1509","article-title":"Diethylstilbestrol (DES) pregnancy treatment : a promising widely used therapy with unintended adverse consequences","volume":"17","author":"Herbst","year":"2015","journal-title":"AMA J Ethics"},{"key":"10.1016\/j.jogoh.2023.102630_bib0007","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1056\/NEJMc1800097","article-title":"Follow-up of patients with clear-cell adenocarcinoma of the vagina and cervix","volume":"378","author":"Huo","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jogoh.2023.102630_bib0008","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.gore.2019.01.012","article-title":"POLE-mutated clear cell cervical cancer associated with in-utero diethylstilbestrol exposure","volume":"28","author":"Lee","year":"2019","journal-title":"Gynecol Oncol Rep"},{"key":"10.1016\/j.jogoh.2023.102630_bib0009","first-page":"1121","article-title":"Risk of clear-cell adenocarcinoma of the vagina and cervix among US women with potential exposure to diethylstilbestrol in utero","volume":"33","author":"White","year":"2022","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.jogoh.2023.102630_bib0010","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/LGT.0000000000000713","article-title":"Postmenopausal vaginal and cervical cancer risk related to in utero diethylstilbestrol exposure","volume":"27","author":"Wamakima","year":"2023","journal-title":"J Low Genit Tract Dis"},{"key":"10.1016\/j.jogoh.2023.102630_bib0011","unstructured":"Agence Fran\u00e7aise de S\u00e9curit\u00e9 SAnitaire des Produits de Sant\u00e9 (AFSSAPS) - Mise au point: Complications li\u00e9es \u00e0 l'exposition in utero au diethylstilbestrol (DES) (Distilb\u00e8ne\u00ae, Stilboestrol-Borne\u00ae) (2011). Avalaible at: https:\/\/ansm.sante.fr\/uploads\/2021\/03\/11\/a2abb4db0658b1c97ade1be777f219ce.pdf [accessed on March 16, 2023]."},{"key":"10.1016\/j.jogoh.2023.102630_bib0012","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/ijc.22631","article-title":"Cancer risk in women prenatally exposed to diethylstilbestrol","volume":"121","author":"Troisi","year":"2007","journal-title":"Intern J of Cancer"},{"key":"10.1016\/j.jogoh.2023.102630_bib0013","unstructured":"Cancer Council Australia. Clinical Guidelines. Cervical cancer screening in DES-exposed women (2022). Available at: https:\/\/www.cancer.org.au\/clinical-guidelines\/cervical-cancer-screening\/screening-in-des-exposed-women [accessed on March 16, 2023]."},{"key":"10.1016\/j.jogoh.2023.102630_bib0014","first-page":"837","article-title":"Incidence of squamous neoplasia of the cervix and vagina in women exposed prenatally to diethylstilbestrol (United States)","volume":"12","author":"Hatch","year":"2001","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.jogoh.2023.102630_bib0015","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ygyno.2016.11.048","article-title":"Risk of cervical intra-epithelial neoplasia and invasive cancer of the cervix in DES daughters","volume":"144","author":"Verloop","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jogoh.2023.102630_bib0016","first-page":"321","article-title":"Cervical cancer screening for individuals at average risk: 2020 guideline update from the american cancer society","volume":"70","author":"Fontham","year":"2020","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"10.1016\/j.jogoh.2023.102630_bib0017","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2018.10897","article-title":"Screening for cervical cancer: US preventive services task force recommendation statement","volume":"320","author":"Preventive Services Task Force","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jogoh.2023.102630_bib0018","unstructured":"American College of Obstetricians and Gynecologists (ACOG). Updated guidelines for management of cervical cancer screening abnormalities. 2020, Reaffirmed September 2022. Available at: https:\/\/www.acog.org\/clinical\/clinical-guidance\/practice-advisory\/articles\/2020\/10\/updated-guidelines-for-management-of-cervical-cancer-screening-abnormalities [accessed on March 16, 2023]."},{"key":"10.1016\/j.jogoh.2023.102630_bib0019","unstructured":"Haute Autorit\u00e9 de Sant\u00e9 (HAS). \u00c9valuation de la recherche des papillomavirus humains (HPV) en d\u00e9pistage primaire des l\u00e9sions pr\u00e9canc\u00e9reuses et canc\u00e9reuses du col de l'ut\u00e9rus et de la place du double immuno-marquage p16\/Ki67 (2019). Available at: https:\/\/www.has-sante.fr\/jcms\/c_2806160\/fr\/evaluation-de-la-recherche-des-papillomavirus-humains-hpv-en-depistage-primaire-des-lesions-precancereuses-et-cancereuses-du-col-de-l-uterus-et-de-la-place-du-double-immuno-marquage-p16\/ki67 [accessed on March 16, 2023]."},{"key":"10.1016\/j.jogoh.2023.102630_bib0020","unstructured":"Institut National du Cancer (INCa). D\u00e9pistage du cancer du col de l'ut\u00e9rus \u2013 Le d\u00e9pistage de 25 \u00e0 65 ans (2023). Available at: https:\/\/www.e-cancer.fr\/Professionnels-de-sante\/Depistage-et-detection-precoce\/Depistage-du-cancer-du-col-de-l-uterus\/Le-depistage-de-25-a-65-ans [accessed on March 16, 2023]."},{"key":"10.1016\/j.jogoh.2023.102630_bib0021","unstructured":"Levadou A, Tournaire M. Distilb\u00e8ne (DES) trois g\u00e9n\u00e9rations. Guide pratique pour les professionnels de sant\u00e9 et les familles DES. Association R\u00e9seau D.E.S. France ( 2021). Available at: https:\/\/www.des-france.org\/wp-content\/uploads\/2021\/12\/Distilbene-Guide-Pratique-Resesau-DES-France-34-pages-Septembre-2021.pdf [accessed on March 16, 2023]."},{"key":"10.1016\/j.jogoh.2023.102630_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.jogoh.2020.102042","article-title":"Screening for cancers of cervix and vagina for women exposed to diethylstibestrol (DES) in utero","volume":"50","author":"Tournaire","year":"2021","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"10.1016\/j.jogoh.2023.102630_bib0023","unstructured":"American College of Obstetricians and Gynecologists (ACOG). Updated cervical cancer screening guidelines (2021). Available at : https:\/\/www.acog.org\/clinical\/clinical-guidance\/practice-advisory\/articles\/2021\/04\/updated-cervical-cancer-screening-guidelines [accessed on March 23, 2023]."},{"key":"10.1016\/j.jogoh.2023.102630_bib0024","unstructured":"National Cancer Institute (NCI). Diethylstilbestrol (DES) Exposure and Cancer (2021). Available at: https:\/\/www.cancer.gov\/about-cancer\/causes-prevention\/risk\/hormones\/des-fact-sheet#what-should-des-daughters-do [accessed on March 23, 2023]."},{"key":"10.1016\/j.jogoh.2023.102630_bib0025","unstructured":"Institut National du Cancer (INCa). Etes-vous concern\u00e9e par le d\u00e9pistage du cancer du col de l'ut\u00e9rus ? (2023). Available at: https:\/\/www.e-cancer.fr\/Comprendre-prevenir-depister\/Se-faire-depister\/Depistage-du-cancer-du-col-de-l-uterus\/Etes-vous-concernee#toc-j-ai-t-expos-e-au-distilb-ne- [accessed on March 16, 2023]."},{"key":"10.1016\/j.jogoh.2023.102630_bib0026","first-page":"239","article-title":"Nouvelle classification fran\u00e7aise des images colposcopiques [Revision of the French colposcopic terminology]","volume":"5","author":"Mergui","year":"2023","journal-title":"Gynecol Obstet Fertil Senol."}],"container-title":["Journal of Gynecology Obstetrics and Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468784723000971?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468784723000971?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T10:02:58Z","timestamp":1762855378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468784723000971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S2468784723000971"],"URL":"https:\/\/doi.org\/10.1016\/j.jogoh.2023.102630","relation":{},"ISSN":["2468-7847"],"issn-type":[{"value":"2468-7847","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Late cervical and vaginal clear cell adenocarcinoma in women exposed in utero to diethylstilbestrol: Evaluation and screening","name":"articletitle","label":"Article Title"},{"value":"Journal of Gynecology Obstetrics and Human Reproduction","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jogoh.2023.102630","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102630"}}